The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations. From Wikipedia
Under Secretary Robert F. Kennedy Jr., the new policy marks a major shift in vaccine approval standards, sparking fears of delays in updated COVID-19 shots and ethical challenges.
